><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Platanias</surname><given-names>LC</given-names></name></person-group><article-title>Mechanisms of type-I- and type-II-interferon-mediated signalling</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>:<fpage>375</fpage>&#x02013;<lpage>86</lpage><pub-id pub-id-type="doi">10.1038/nri1604</pub-id><?supplied-pmid 15864272?><pub-id pub-id-type="pmid">15864272</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borden</surname><given-names>EC</given-names></name><name><surname>Sen</surname><given-names>GC</given-names></name><name><surname>Uze</surname><given-names>G</given-names></name><name><surname>Silverman</surname><given-names>RH</given-names></name><name><surname>Ransohoff</surname><given-names>RM</given-names></name><name><surname>Foster</surname><given-names>GR</given-names></name><etal/></person-group>
<article-title>Interferons at age 50: past, current and future impact on biomedicine</article-title>. <source>Nat Rev Drug Discov</source> (<year>2007</year>) <volume>6</volume>:<fpage>975</fpage>&#x02013;<lpage>90</lpage><pub-id pub-id-type="doi">10.1038/nrd2422</pub-id><?supplied-pmid 18049472?><pub-id pub-id-type="pmid">18049472</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>WM</given-names></name><name><surname>Chevillotte</surname><given-names>MD</given-names></name><name><surname>Rice</surname><given-names>CM</given-names></name></person-group>
<article-title>Interferon-stimulated genes: a complex web of host defenses</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>513</fpage>&#x02013;<lpage>45</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120231</pub-id><?supplied-pmid 24555472?><pub-id pub-id-type="pmid">24555472</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pestka</surname><given-names>S</given-names></name></person-group>
<article-title>The interferons: 50 years after their discovery, there is much more to learn</article-title>. <source>J Biol Chem</source> (<year>2007</year>) <volume>282</volume>:<fpage>20047</fpage>&#x02013;<lpage>51</lpage><pub-id pub-id-type="doi">10.1074/jbc.R700004200</pub-id><?supplied-pmid 17502369?><pub-id pub-id-type="pmid">17502369</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>S</given-names></name><name><surname>Delgado</surname><given-names>C</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>
<article-title>Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections</article-title>. <source>Immunol Res</source> (<year>2012</year>) <volume>55</volume>:<fpage>187</fpage>&#x02013;<lpage>200</lpage><pub-id pub-id-type="doi">10.1007/s12026-012-8362-y</pub-id><?supplied-pmid 22983898?><pub-id pub-id-type="pmid">22983898</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bracarda</surname><given-names>S</given-names></name><name><surname>Eggermont</surname><given-names>AMM</given-names></name><name><surname>Samuelsson</surname><given-names>J</given-names></name></person-group>
<article-title>Redefining the role of interferon in the treatment of malignant diseases</article-title>. <source>Eur J Cancer</source> (<year>2010</year>) <volume>46</volume>:<fpage>284</fpage>&#x02013;<lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.ejca.2009.10.013</pub-id><?supplied-pmid 19906524?><pub-id pub-id-type="pmid">19906524</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Boxel-Dezaire</surname><given-names>AHH</given-names></name><name><surname>Rani</surname><given-names>MRS</given-names></name><name><surname>Stark</surname><given-names>GR</given-names></name></person-group>
<article-title>Complex modulation of cell type-specific signaling in response to type I interferons</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>25</volume>:<fpage>361</fpage>&#x02013;<lpage>72</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.08.014</pub-id><?supplied-pmid 16979568?><pub-id pub-id-type="pmid">16979568</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>C</given-names></name><name><surname>Moraga</surname><given-names>I</given-names></name><name><surname>Levin</surname><given-names>D</given-names></name><name><surname>Krutzik</surname><given-names>PO</given-names></name><name><surname>Podoplelova</surname><given-names>Y</given-names></name><name><surname>Trejo</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Structural linkage between ligand discrimination and receptor activation by type I interferons</article-title>. <source>Cell</source> (<year>2011</year>) <volume>146</volume>:<fpage>621</fpage>&#x02013;<lpage>32</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2011.06.048</pub-id><?supplied-pmid 21854986?><pub-id pub-id-type="pmid">21854986</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berg</surname><given-names>RE</given-names></name><name><surname>Crossley</surname><given-names>E</given-names></name><name><surname>Murray</surname><given-names>S</given-names></name><name><surname>Forman</surname><given-names>J</given-names></name></person-group>
<article-title>Memory CD8+ T cells provide innate immune protection against <italic>Listeria monocytogenes</italic> in the absence of cognate antigen</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>198</volume>:<fpage>1583</fpage>&#x02013;<lpage>93</lpage><pub-id pub-id-type="doi">10.1084/jem.20031051</pub-id><?supplied-pmid 14623912?><pub-id pub-id-type="pmid">14623912</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Humann</surname><given-names>J</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>
<article-title>Activation of naive NK cells in response to <italic>Listeria monocytogenes</italic> requires IL-18 and contact with infected dendritic cells</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>5172</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0903759</pub-id><pub-id pub-id-type="pmid">20351186</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soudja</surname><given-names>SM</given-names></name><name><surname>Ruiz</surname><given-names>AL</given-names></name><name><surname>Marie</surname><given-names>JC</given-names></name><name><surname>Lauvau</surname><given-names>G</given-names></name></person-group>
<article-title>Inflammatory monocytes activate memory CD8(+) T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>37</volume>:<fpage>549</fpage>&#x02013;<lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2012.05.029</pub-id><?supplied-pmid 22940097?><pub-id pub-id-type="pmid">22940097</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dighe</surname><given-names>AS</given-names></name><name><surname>Campbell</surname><given-names>D</given-names></name><name><surname>Hsieh</surname><given-names>CS</given-names></name><name><surname>Clarke</surname><given-names>S</given-names></name><name><surname>Greaves</surname><given-names>DR</given-names></name><name><surname>Gordon</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Tissue-specific targeting of cytokine unresponsiveness in transgenic mice</article-title>. <source>Immunity</source> (<year>1995</year>) <volume>3</volume>:<fpage>657</fpage>&#x02013;<lpage>66</lpage><pub-id pub-id-type="doi">10.1016/1074-7613(95)90136-1</pub-id><?supplied-pmid 7584155?><pub-id pub-id-type="pmid">7584155</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Carrero</surname><given-names>JA</given-names></name><name><surname>Uppaluri</surname><given-names>R</given-names></name><name><surname>White</surname><given-names>JM</given-names></name><name><surname>Archambault</surname><given-names>JM</given-names></name><name><surname>Lai</surname><given-names>KS</given-names></name><etal/></person-group>
<article-title>Identifying the initiating events of anti-<italic>Listeria</italic> responses using mice with conditional loss of IFN-&#x003b3; receptor subunit 1 (IFNGR1)</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<fpage>4223</fpage>&#x02013;<lpage>34</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1300910</pub-id><?supplied-pmid 24048899?><pub-id pub-id-type="pmid">24048899</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacMicking</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Q</given-names></name><name><surname>Nathan</surname><given-names>C</given-names></name></person-group>
<article-title>Nitric oxide and macrophage function</article-title>. <source>Annu Rev Immunol</source> (<year>1997</year>) <volume>15</volume>:<fpage>323</fpage>&#x02013;<lpage>50</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.15.1.323</pub-id><?supplied-pmid 9143691?><pub-id pub-id-type="pmid">9143691</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumatori</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Suzuki</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>M</given-names></name></person-group>
<article-title>Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene</article-title>. <source>J Biol Chem</source> (<year>2002</year>) <volume>277</volume>:<fpage>9103</fpage>&#x02013;<lpage>11</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109803200</pub-id><?supplied-pmid 11781315?><pub-id pub-id-type="pmid">11781315</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunn</surname><given-names>JP</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name><name><surname>Howard</surname><given-names>JC</given-names></name></person-group>
<article-title>The immunity-related GTPases in mammals: a fast-evolving cell-autonomous resistance system against intracellular pathogens</article-title>. <source>Mamm Genome</source> (<year>2011</year>) <volume>22</volume>:<fpage>43</fpage>&#x02013;<lpage>54</lpage><pub-id pub-id-type="doi">10.1007/s00335-010-9293-3</pub-id><?supplied-pmid 21052678?><pub-id pub-id-type="pmid">21052678</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>B-H</given-names></name><name><surname>Shenoy</surname><given-names>AR</given-names></name><name><surname>Kumar</surname><given-names>P</given-names></name><name><surname>Bradfield</surname><given-names>CJ</given-names></name><name><surname>MacMicking</surname><given-names>JD</given-names></name></person-group>
<article-title>IFN-inducible GTPases in host cell defense</article-title>. <source>Cell Host Microbe</source> (<year>2012</year>) <volume>12</volume>:<fpage>432</fpage>&#x02013;<lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2012.09.007</pub-id><?supplied-pmid 23084913?><pub-id pub-id-type="pmid">23084913</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>GA</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Sher</surname><given-names>A</given-names></name></person-group>
<article-title>Control of IFN-gamma-mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases)</article-title>. <source>Microbes Infect</source> (<year>2007</year>) <volume>9</volume>:<fpage>1644</fpage>&#x02013;<lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.micinf.2007.09.004</pub-id><?supplied-pmid 18023232?><pub-id pub-id-type="pmid">18023232</pub-id></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schroder</surname><given-names>K</given-names></name><name><surname>Hertzog</surname><given-names>PJ</given-names></name><name><surname>Ravasi</surname><given-names>T</given-names></name><name><surname>Hume</surname><given-names>DA</given-names></name></person-group>
<article-title>Interferon-gamma: an overview of signals, mechanisms and functions</article-title>. <source>J Leukoc Biol</source> (<year>2004</year>) <volume>75</volume>:<fpage>164</fpage>&#x02013;<lpage>89</lpage><pub-id pub-id-type="doi">10.1189/jlb.0603252.Journal</pub-id><?supplied-pmid 14525967?><pub-id pub-id-type="pmid">14525967</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baldridge</surname><given-names>MT</given-names></name><name><surname>King</surname><given-names>KY</given-names></name><name><surname>Boles</surname><given-names>NC</given-names></name><name><surname>Weksberg</surname><given-names>DC</given-names></name><name><surname>Goodell</surname><given-names>MA</given-names></name></person-group>
<article-title>Quiescent haematopoietic stem cells are activated by IFN-gamma in response to chronic infection</article-title>. <source>Nature</source> (<year>2010</year>) <volume>465</volume>:<fpage>793</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nature09135</pub-id><?supplied-pmid 20535209?><pub-id pub-id-type="pmid">20535209</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacNamara</surname><given-names>KC</given-names></name><name><surname>Oduro</surname><given-names>K</given-names></name><name><surname>Martin</surname><given-names>O</given-names></name><name><surname>Jones</surname><given-names>DD</given-names></name><name><surname>McLaughlin</surname><given-names>M</given-names></name><name><surname>Choi</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Infection-induced myelopoiesis during intracellular bacterial infection is critically dependent upon IFN-&#x003b3; signaling</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>1032</fpage>&#x02013;<lpage>43</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1001893</pub-id><?supplied-pmid 21149601?><pub-id pub-id-type="pmid">21149601</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M</given-names></name><name><surname>Humann</surname><given-names>J</given-names></name><name><surname>Kearney</surname><given-names>S</given-names></name><name><surname>Hill</surname><given-names>KK</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>
<article-title>Antagonistic crosstalk between type I and II interferons and increased host susceptibility to bacterial infections</article-title>. <source>Virulence</source> (<year>2010</year>) <volume>1</volume>:<fpage>418</fpage>&#x02013;<lpage>22</lpage><pub-id pub-id-type="doi">10.1084/jem.20091746.ype</pub-id><?supplied-pmid 21178482?><pub-id pub-id-type="pmid">21178482</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Decker</surname><given-names>T</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M</given-names></name><name><surname>Stockinger</surname><given-names>S</given-names></name></person-group>
<article-title>The yin and yang of type I interferon activity in bacterial infection</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>:<fpage>675</fpage>&#x02013;<lpage>87</lpage><pub-id pub-id-type="doi">10.1038/nri1684</pub-id><?supplied-pmid 16110316?><pub-id pub-id-type="pmid">16110316</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malireddi</surname><given-names>RKS</given-names></name><name><surname>Kanneganti</surname><given-names>T-D</given-names></name></person-group>
<article-title>Role of type I interferons in inflammasome activation, cell death, and disease during microbial infection</article-title>. <source>Front Cell Infect Microbiol</source> (<year>2013</year>) <volume>3</volume>:<fpage>77</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2013.00077</pub-id><?supplied-pmid 24273750?><pub-id pub-id-type="pmid">24273750</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mostowy</surname><given-names>S</given-names></name><name><surname>Cossart</surname><given-names>P</given-names></name></person-group>
<article-title>Cytoskeleton rearrangements during <italic>Listeria</italic> infection: clathrin and septins as new players in the game</article-title>. <source>Cell Motil Cytoskeleton</source> (<year>2009</year>) <volume>66</volume>:<fpage>816</fpage>&#x02013;<lpage>23</lpage><pub-id pub-id-type="doi">10.1002/cm.20353</pub-id><?supplied-pmid 19296488?><pub-id pub-id-type="pmid">19296488</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ireton</surname><given-names>K</given-names></name></person-group>
<article-title>Entry of the bacterial pathogen <italic>Listeria monocytogenes</italic> into mammalian cells</article-title>. <source>Cell Microbiol</source> (<year>2007</year>) <volume>9</volume>:<fpage>1365</fpage>&#x02013;<lpage>75</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.00933.x</pub-id><?supplied-pmid 17419717?><pub-id pub-id-type="pmid">17419717</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Portnoy</surname><given-names>D</given-names></name><name><surname>Jacks</surname><given-names>P</given-names></name><name><surname>Hinrichs</surname><given-names>D</given-names></name></person-group>
<article-title>Role of hemolysin for the intracellular growth of <italic>Listeria monocytogenes</italic></article-title>. <source>J Exp Med</source> (<year>1988</year>) <volume>167</volume>:<fpage>1459</fpage>&#x02013;<lpage>71</lpage><pub-id pub-id-type="doi">10.1084/jem.167.4.1459</pub-id><?supplied-pmid 2833557?><pub-id pub-id-type="pmid">2833557</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaffrey</surname><given-names>RL</given-names></name><name><surname>Fawcett</surname><given-names>P</given-names></name><name><surname>O&#x02019;Riordan</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>K-D</given-names></name><name><surname>Havell</surname><given-names>EA</given-names></name><name><surname>Brown</surname><given-names>PO</given-names></name><etal/></person-group>
<article-title>A specific gene expression program triggered by Gram-positive bacteria in the cytosol</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2004</year>) <volume>101</volume>:<fpage>11386</fpage>&#x02013;<lpage>91</lpage><pub-id pub-id-type="doi">10.1073/pnas.0403215101</pub-id><?supplied-pmid 15269347?><pub-id pub-id-type="pmid">15269347</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leber</surname><given-names>JH</given-names></name><name><surname>Crimmins</surname><given-names>GT</given-names></name><name><surname>Raghavan</surname><given-names>S</given-names></name><name><surname>Meyer-Morse</surname><given-names>NP</given-names></name><name><surname>Cox</surname><given-names>JS</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>
<article-title>Distinct TLR- and NLR-mediated transcriptional responses to an intracellular pathogen</article-title>. <source>PLoS Pathog</source> (<year>2008</year>) <volume>4</volume>:<fpage>e6</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.0040006</pub-id><?supplied-pmid 18193943?><pub-id pub-id-type="pmid">18193943</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aubry</surname><given-names>C</given-names></name><name><surname>Corr</surname><given-names>SC</given-names></name><name><surname>Wienerroither</surname><given-names>S</given-names></name><name><surname>Goulard</surname><given-names>C</given-names></name><name><surname>Jones</surname><given-names>R</given-names></name><name><surname>Jamieson</surname><given-names>AM</given-names></name><etal/></person-group>
<article-title>Both TLR2 and TRIF contribute to interferon-&#x003b2; production during <italic>Listeria</italic> infection</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>:<fpage>e33299</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0033299</pub-id><?supplied-pmid 22432012?><pub-id pub-id-type="pmid">22432012</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>J-H</given-names></name><name><surname>Kim</surname><given-names>Y-G</given-names></name><name><surname>McDonald</surname><given-names>C</given-names></name><name><surname>Kanneganti</surname><given-names>T-D</given-names></name><name><surname>Hasegawa</surname><given-names>M</given-names></name><name><surname>Body-Malapel</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>RICK/RIP2 mediates innate immune responses induced through Nod1 and Nod2 but not TLRs</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>2380</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.4.2380</pub-id><?supplied-pmid 17277144?><pub-id pub-id-type="pmid">17277144</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Inohara</surname><given-names>N</given-names></name><name><surname>Hernandez</surname><given-names>LD</given-names></name><name><surname>Gal&#x000e1;n</surname><given-names>JE</given-names></name><name><surname>N&#x000fa;&#x000f1;ez</surname><given-names>G</given-names></name><name><surname>Janeway</surname><given-names>CA</given-names></name><etal/></person-group>
<article-title>RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems</article-title>. <source>Nature</source> (<year>2002</year>) <volume>416</volume>:<fpage>194</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1038/416194a</pub-id><?supplied-pmid 11894098?><pub-id pub-id-type="pmid">11894098</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chin</surname><given-names>AI</given-names></name><name><surname>Dempsey</surname><given-names>PW</given-names></name><name><surname>Bruhn</surname><given-names>K</given-names></name><name><surname>Miller</surname><given-names>JF</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>
<article-title>Involvement of receptor-interacting protein 2 in innate and adaptive immune responses</article-title>. <source>Nature</source> (<year>2002</year>) <volume>416</volume>:<fpage>190</fpage>&#x02013;<lpage>4</lpage><pub-id pub-id-type="doi">10.1038/416190a</pub-id><?supplied-pmid 11894097?><pub-id pub-id-type="pmid">11894097</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname><given-names>R</given-names></name><name><surname>Vaidya</surname><given-names>S</given-names></name><name><surname>Perry</surname><given-names>AK</given-names></name><name><surname>Saha</surname><given-names>SK</given-names></name><name><surname>Dempsey</surname><given-names>PW</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name></person-group>
<article-title>Immune activation of type I IFNs by <italic>Listeria monocytogenes</italic> occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TANK-binding kinase</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>:<fpage>1602</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.174.3.1602</pub-id><?supplied-pmid 15661922?><pub-id pub-id-type="pmid">15661922</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stockinger</surname><given-names>S</given-names></name><name><surname>Reutterer</surname><given-names>B</given-names></name><name><surname>Schaljo</surname><given-names>B</given-names></name><name><surname>Schellack</surname><given-names>C</given-names></name><name><surname>Brunner</surname><given-names>S</given-names></name><name><surname>Materna</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>:<fpage>7416</fpage>&#x02013;<lpage>25</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.12.7416</pub-id><?supplied-pmid 15585867?><pub-id pub-id-type="pmid">15585867</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stetson</surname><given-names>DB</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name></person-group>
<article-title>Recognition of cytosolic DNA activates an IRF3-dependent innate immune response</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>24</volume>:<fpage>93</fpage>&#x02013;<lpage>103</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2005.12.003</pub-id><?supplied-pmid 16413926?><pub-id pub-id-type="pmid">16413926</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdullah</surname><given-names>Z</given-names></name><name><surname>Schlee</surname><given-names>M</given-names></name><name><surname>Roth</surname><given-names>S</given-names></name><name><surname>Mraheil</surname><given-names>MA</given-names></name><name><surname>Barchet</surname><given-names>W</given-names></name><name><surname>B&#x000f6;ttcher</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>RIG-I detects infection with live <italic>Listeria</italic> by sensing secreted bacterial nucleic acids</article-title>. <source>EMBO J</source> (<year>2012</year>) <volume>31</volume>:<fpage>4153</fpage>&#x02013;<lpage>64</lpage><pub-id pub-id-type="doi">10.1038/emboj.2012.274</pub-id><?supplied-pmid 23064150?><pub-id pub-id-type="pmid">23064150</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loo</surname><given-names>Y-M</given-names></name><name><surname>Gale</surname><given-names>M</given-names></name></person-group>
<article-title>Immune signaling by RIG-I-like receptors</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<fpage>680</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.003</pub-id><pub-id pub-id-type="pmid">21616437</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vabret</surname><given-names>N</given-names></name><name><surname>Blander</surname><given-names>JM</given-names></name></person-group>
<article-title>Sensing microbial RNA in the cytosol</article-title>. <source>Front Immunol</source> (<year>2013</year>) <volume>4</volume>:<fpage>468</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2013.00468</pub-id><?supplied-pmid 24400006?><pub-id pub-id-type="pmid">24400006</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>
<article-title>Innate immune sensing and signaling of cytosolic nucleic acids</article-title>. <source>Annu Rev Immunol</source> (<year>2014</year>) <volume>32</volume>:<fpage>461</fpage>&#x02013;<lpage>88</lpage><pub-id pub-id-type="doi">10.1146/annurev-immunol-032713-120156</pub-id><?supplied-pmid 24655297?><pub-id pub-id-type="pmid">24655297</pub-id></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>RB</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Ea</surname><given-names>C-K</given-names></name><name><surname>Chen</surname><given-names>ZJ</given-names></name></person-group>
<article-title>Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3</article-title>. <source>Cell</source> (<year>2005</year>) <volume>122</volume>:<fpage>669</fpage>&#x02013;<lpage>82</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.08.012</pub-id><?supplied-pmid 16125763?><pub-id pub-id-type="pmid">16125763</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L-G</given-names></name><name><surname>Wang</surname><given-names>Y-Y</given-names></name><name><surname>Han</surname><given-names>K-J</given-names></name><name><surname>Li</surname><given-names>L-Y</given-names></name><name><surname>Zhai</surname><given-names>Z</given-names></name><name><surname>Shu</surname><given-names>H-B</given-names></name></person-group>
<article-title>VISA is an adapter protein required for virus-triggered IFN-beta signaling</article-title>. <source>Mol Cell</source> (<year>2005</year>) <volume>19</volume>:<fpage>727</fpage>&#x02013;<lpage>40</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.08.014</pub-id><?supplied-pmid 16153868?><pub-id pub-id-type="pmid">16153868</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meylan</surname><given-names>E</given-names></name><name><surname>Curran</surname><given-names>J</given-names></name><name><surname>Hofmann</surname><given-names>K</given-names></name><name><surname>Moradpour</surname><given-names>D</given-names></name><name><surname>Binder</surname><given-names>M</given-names></name><name><surname>Bartenschlager</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus</article-title>. <source>Nature</source> (<year>2005</year>) <volume>437</volume>:<fpage>1167</fpage>&#x02013;<lpage>72</lpage><pub-id pub-id-type="doi">10.1038/nature04193</pub-id><?supplied-pmid 16177806?><pub-id pub-id-type="pmid">16177806</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Q</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>H-H</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Seth</surname><given-names>RB</given-names></name><name><surname>Forman</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>The specific and essential role of MAVS in antiviral innate immune responses</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>24</volume>:<fpage>633</fpage>&#x02013;<lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2006.04.004</pub-id><?supplied-pmid 16713980?><pub-id pub-id-type="pmid">16713980</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soulat</surname><given-names>D</given-names></name><name><surname>Bauch</surname><given-names>A</given-names></name><name><surname>Stockinger</surname><given-names>S</given-names></name><name><surname>Superti-Furga</surname><given-names>G</given-names></name><name><surname>Decker</surname><given-names>T</given-names></name></person-group>
<article-title>Cytoplasmic <italic>Listeria monocytogenes</italic> stimulates IFN-beta synthesis without requiring the adapter protein MAVS</article-title>. <source>FEBS Lett</source> (<year>2006</year>) <volume>580</volume>:<fpage>2341</fpage>&#x02013;<lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2006.03.057</pub-id><?supplied-pmid 16616525?><pub-id pub-id-type="pmid">16616525</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hagmann</surname><given-names>CA</given-names></name><name><surname>Herzner</surname><given-names>AM</given-names></name><name><surname>Abdullah</surname><given-names>Z</given-names></name><name><surname>Zillinger</surname><given-names>T</given-names></name><name><surname>Jakobs</surname><given-names>C</given-names></name><name><surname>Schuberth</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>RIG-I detects triphosphorylated RNA of <italic>Listeria monocytogenes</italic> during infection in non-immune cells</article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e62872</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0062872</pub-id><?supplied-pmid 23653683?><pub-id pub-id-type="pmid">23653683</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monroe</surname><given-names>KM</given-names></name><name><surname>McWhirter</surname><given-names>SM</given-names></name><name><surname>Vance</surname><given-names>RE</given-names></name></person-group>
<article-title>Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to <italic>Legionella pneumophila</italic></article-title>. <source>PLoS Pathog</source> (<year>2009</year>) <volume>5</volume>:<fpage>e1000665</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1000665</pub-id><?supplied-pmid 19936053?><pub-id pub-id-type="pmid">19936053</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unterholzner</surname><given-names>L</given-names></name><name><surname>Keating</surname><given-names>SE</given-names></name><name><surname>Baran</surname><given-names>M</given-names></name><name><surname>Horan</surname><given-names>KA</given-names></name><name><surname>Jensen</surname><given-names>SB</given-names></name><name><surname>Sharma</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>IFI16 is an innate immune sensor for intracellular DNA</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>:<fpage>997</fpage>&#x02013;<lpage>1004</lpage><pub-id pub-id-type="doi">10.1038/ni.1932</pub-id><?supplied-pmid 20890285?><pub-id pub-id-type="pmid">20890285</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>An</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Wen</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Rui</surname><given-names>Y</given-names></name><etal/></person-group>
<article-title>The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway</article-title>. <source>Nat Immunol</source> (<year>2010</year>) <volume>11</volume>:<fpage>487</fpage>&#x02013;<lpage>94</lpage><pub-id pub-id-type="doi">10.1038/ni.1876</pub-id><?supplied-pmid 20453844?><pub-id pub-id-type="pmid">20453844</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lippmann</surname><given-names>J</given-names></name><name><surname>Rothenburg</surname><given-names>S</given-names></name><name><surname>Deigendesch</surname><given-names>N</given-names></name><name><surname>Eitel</surname><given-names>J</given-names></name><name><surname>Meixenberger</surname><given-names>K</given-names></name><name><surname>van Laak</surname><given-names>V</given-names></name><etal/></person-group>
<article-title>IFNbeta responses induced by intracellular bacteria or cytosolic DNA in different human cells do not require ZBP1 (DLM-1/DAI)</article-title>. <source>Cell Microbiol</source> (<year>2008</year>) <volume>10</volume>:<fpage>2579</fpage>&#x02013;<lpage>88</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2008.01232.x</pub-id><?supplied-pmid 18771559?><pub-id pub-id-type="pmid">18771559</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>K</given-names></name><name><surname>Prabakaran</surname><given-names>T</given-names></name><name><surname>Laustsen</surname><given-names>A</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>SE</given-names></name><name><surname>Rahb&#x000e6;k</surname><given-names>SH</given-names></name><name><surname>Jensen</surname><given-names>SB</given-names></name><etal/></person-group>
<article-title><italic>Listeria monocytogenes</italic> induces IFN&#x003b2; expression through an IFI16-, cGAS- and STING-dependent pathway</article-title>. <source>EMBO J</source> (<year>2014</year>) <volume>33</volume>:<fpage>1654</fpage>&#x02013;<lpage>66</lpage><pub-id pub-id-type="doi">10.15252/embj.201488029</pub-id><?supplied-pmid 24970844?><pub-id pub-id-type="pmid">24970844</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Yuan</surname><given-names>B</given-names></name><name><surname>Bao</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>N</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y-J</given-names></name></person-group>
<article-title>The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells</article-title>. <source>Nat Immunol</source> (<year>2011</year>) <volume>12</volume>:<fpage>959</fpage>&#x02013;<lpage>65</lpage><pub-id pub-id-type="doi">10.1038/ni.2091</pub-id><?supplied-pmid 21892174?><pub-id pub-id-type="pmid">21892174</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taniguchi</surname><given-names>T</given-names></name><name><surname>Ogasawara</surname><given-names>K</given-names></name><name><surname>Takaoka</surname><given-names>A</given-names></name><name><surname>Tanaka</surname><given-names>N</given-names></name></person-group>
<article-title>IRF family of transcription factors as regulators of host defense</article-title>. <source>Annu Rev Immunol</source> (<year>2001</year>) <volume>19</volume>:<fpage>623</fpage>&#x02013;<lpage>55</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.623</pub-id><?supplied-pmid 11244049?><pub-id pub-id-type="pmid">11244049</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Connell</surname><given-names>RM</given-names></name><name><surname>Saha</surname><given-names>SK</given-names></name><name><surname>Vaidya</surname><given-names>SA</given-names></name><name><surname>Bruhn</surname><given-names>KW</given-names></name><name><surname>Miranda</surname><given-names>GA</given-names></name><name><surname>Zarnegar</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>Type I interferon production enhances susceptibility to <italic>Listeria monocytogenes</italic> infection</article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>200</volume>:<fpage>437</fpage>&#x02013;<lpage>45</lpage><pub-id pub-id-type="doi">10.1084/jem.20040712</pub-id><?supplied-pmid 15302901?><pub-id pub-id-type="pmid">15302901</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishikawa</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Barber</surname><given-names>GN</given-names></name></person-group>
<article-title>STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity</article-title>. <source>Nature</source> (<year>2009</year>) <volume>461</volume>:<fpage>788</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.1038/nature08476</pub-id><?supplied-pmid 19776740?><pub-id pub-id-type="pmid">19776740</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>L</given-names></name><name><surname>Hill</surname><given-names>KK</given-names></name><name><surname>Filak</surname><given-names>H</given-names></name><name><surname>Mogan</surname><given-names>J</given-names></name><name><surname>Knowles</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><etal/></person-group>
<article-title>MPYS is required for IFN response factor 3 activation and type I IFN production in the response of cultured phagocytes to bacterial second messengers cyclic-di-AMP and cyclic-di-GMP</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>2595</fpage>&#x02013;<lpage>601</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100088</pub-id><?supplied-pmid 21813776?><pub-id pub-id-type="pmid">21813776</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname><given-names>J-D</given-names></name><name><surname>Sotelo-Troha</surname><given-names>K</given-names></name><name><surname>von Moltke</surname><given-names>J</given-names></name><name><surname>Monroe</surname><given-names>KM</given-names></name><name><surname>Rae</surname><given-names>CS</given-names></name><name><surname>Brubaker</surname><given-names>SW</given-names></name><etal/></person-group>
<article-title>The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of STING in the in vivo interferon response to <italic>Listeria monocytogenes</italic> and cyclic dinucleotides</article-title>. <source>Infect Immun</source> (<year>2011</year>) <volume>79</volume>:<fpage>688</fpage>&#x02013;<lpage>94</lpage><pub-id pub-id-type="doi">10.1128/IAI.00999-10</pub-id><?supplied-pmid 21098106?><pub-id pub-id-type="pmid">21098106</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>F</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>:<fpage>826</fpage>&#x02013;<lpage>30</lpage><pub-id pub-id-type="doi">10.1126/science.1229963</pub-id><?supplied-pmid 23258412?><pub-id pub-id-type="pmid">23258412</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Shi</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><etal/></person-group>
<article-title>Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING</article-title>. <source>Mol Cell</source> (<year>2013</year>) <volume>51</volume>:<fpage>226</fpage>&#x02013;<lpage>35</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2013.05.022</pub-id><?supplied-pmid 23747010?><pub-id pub-id-type="pmid">23747010</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burdette</surname><given-names>DL</given-names></name><name><surname>Monroe</surname><given-names>KM</given-names></name><name><surname>Sotelo-Troha</surname><given-names>K</given-names></name><name><surname>Iwig</surname><given-names>JS</given-names></name><name><surname>Eckert</surname><given-names>B</given-names></name><name><surname>Hyodo</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>STING is a direct innate immune sensor of cyclic di-GMP</article-title>. <source>Nature</source> (<year>2011</year>) <volume>478</volume>:<fpage>515</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nature10429</pub-id><?supplied-pmid 21947006?><pub-id pub-id-type="pmid">21947006</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodward</surname><given-names>JJ</given-names></name><name><surname>Iavarone</surname><given-names>AT</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>
<article-title>c-di-AMP secreted by intracellular <italic>Listeria monocytogenes</italic> activates a host type I interferon response</article-title>. <source>Science</source> (<year>2010</year>) <volume>328</volume>:<fpage>1703</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="doi">10.1126/science.1189801</pub-id><?supplied-pmid 20508090?><pub-id pub-id-type="pmid">20508090</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witte</surname><given-names>CE</given-names></name><name><surname>Whiteley</surname><given-names>AT</given-names></name><name><surname>Burke</surname><given-names>TP</given-names></name><name><surname>Sauer</surname><given-names>J-D</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name><name><surname>Woodward</surname><given-names>JJ</given-names></name></person-group>
<article-title>Cyclic di-AMP is critical for <italic>Listeria monocytogenes</italic> growth, cell wall homeostasis, and establishment of infection</article-title>. <source>MBio</source> (<year>2013</year>) <volume>4</volume>:<fpage>e282</fpage>&#x02013;<lpage>213</lpage><pub-id pub-id-type="doi">10.1128/mBio.00282-13</pub-id><?supplied-pmid 23716572?><pub-id pub-id-type="pmid">23716572</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plumlee</surname><given-names>CR</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Beg</surname><given-names>AA</given-names></name><name><surname>Decker</surname><given-names>T</given-names></name><name><surname>Shuman</surname><given-names>HA</given-names></name><name><surname>Schindler</surname><given-names>C</given-names></name></person-group>
<article-title>Interferons direct an effective innate response to <italic>Legionella pneumophila</italic> infection</article-title>. <source>J Biol Chem</source> (<year>2009</year>) <volume>284</volume>:<fpage>30058</fpage>&#x02013;<lpage>66</lpage><pub-id pub-id-type="doi">10.1074/jbc.M109.018283</pub-id><?supplied-pmid 19720834?><pub-id pub-id-type="pmid">19720834</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancuso</surname><given-names>G</given-names></name><name><surname>Midiri</surname><given-names>A</given-names></name><name><surname>Biondo</surname><given-names>C</given-names></name><name><surname>Beninati</surname><given-names>C</given-names></name><name><surname>Zummo</surname><given-names>S</given-names></name><name><surname>Galbo</surname><given-names>R</given-names></name><etal/></person-group>
<article-title>Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>3126</fpage>&#x02013;<lpage>33</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.178.5.3126</pub-id><?supplied-pmid 17312160?><pub-id pub-id-type="pmid">17312160</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname><given-names>T</given-names></name><name><surname>Aga</surname><given-names>M</given-names></name><name><surname>Hino</surname><given-names>K</given-names></name><name><surname>Ushio</surname><given-names>C</given-names></name><name><surname>Taniguchi</surname><given-names>M</given-names></name><name><surname>Iwaki</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha</article-title>. <source>Biomed Res</source> (<year>2005</year>) <volume>26</volume>:<fpage>179</fpage>&#x02013;<lpage>85</lpage><pub-id pub-id-type="doi">10.2220/biomedres.26.179</pub-id><?supplied-pmid 16152734?><pub-id pub-id-type="pmid">16152734</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fung</surname><given-names>KY</given-names></name><name><surname>Mangan</surname><given-names>NE</given-names></name><name><surname>Cumming</surname><given-names>H</given-names></name><name><surname>Horvat</surname><given-names>JC</given-names></name><name><surname>Mayall</surname><given-names>JR</given-names></name><name><surname>Stifter</surname><given-names>SA</given-names></name><etal/></person-group>
<article-title>Interferon-&#x003f5; protects the female reproductive tract from viral and bacterial infection</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>:<fpage>1088</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.1126/science.1233321</pub-id><?supplied-pmid 23449591?><pub-id pub-id-type="pmid">23449591</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fehr</surname><given-names>BT</given-names></name><name><surname>Schoedon</surname><given-names>G</given-names></name><name><surname>Odermatt</surname><given-names>B</given-names></name><name><surname>Holtschke</surname><given-names>T</given-names></name><name><surname>Schneemann</surname><given-names>M</given-names></name><name><surname>Bachmann</surname><given-names>MF</given-names></name><etal/></person-group>
<article-title>Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis</article-title>. <source>J Exp Med</source> (<year>1997</year>) <volume>185</volume>:<fpage>921</fpage>&#x02013;<lpage>31</lpage><pub-id pub-id-type="doi">10.1084/jem.185.5.921</pub-id><?supplied-pmid 9120398?><pub-id pub-id-type="pmid">9120398</pub-id></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Auerbuch</surname><given-names>V</given-names></name><name><surname>Brockstedt</surname><given-names>DG</given-names></name><name><surname>Meyer-Morse</surname><given-names>N</given-names></name><name><surname>O&#x02019;Riordan</surname><given-names>M</given-names></name><name><surname>Portnoy</surname><given-names>DA</given-names></name></person-group>
<article-title>Mice lacking the type I interferon receptor are resistant to <italic>Listeria monocytogenes</italic></article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>200</volume>:<fpage>527</fpage>&#x02013;<lpage>33</lpage><pub-id pub-id-type="doi">10.1084/jem.20040976</pub-id><?supplied-pmid 15302899?><pub-id pub-id-type="pmid">15302899</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>JA</given-names></name><name><surname>Calderon</surname><given-names>B</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group>
<article-title>Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to <italic>Listeria</italic> infection</article-title>. <source>J Exp Med</source> (<year>2004</year>) <volume>200</volume>:<fpage>535</fpage>&#x02013;<lpage>40</lpage><pub-id pub-id-type="doi">10.1084/jem.20040769</pub-id><?supplied-pmid 15302900?><pub-id pub-id-type="pmid">15302900</pub-id></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rayamajhi</surname><given-names>M</given-names></name><name><surname>Humann</surname><given-names>J</given-names></name><name><surname>Penheiter</surname><given-names>K</given-names></name><name><surname>Andreasen</surname><given-names>K</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>
<article-title>Induction of IFN-alphabeta enables <italic>Listeria monocytogenes</italic> to suppress macrophage activation by IFN-gamma</article-title>. <source>J Exp Med</source> (<year>2010</year>) <volume>207</volume>:<fpage>327</fpage>&#x02013;<lpage>37</lpage><pub-id pub-id-type="doi">10.1084/jem.20091746</pub-id><?supplied-pmid 20123961?><pub-id pub-id-type="pmid">20123961</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henry</surname><given-names>T</given-names></name><name><surname>Kirimanjeswara</surname><given-names>GS</given-names></name><name><surname>Ruby</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>JW</given-names></name><name><surname>Peng</surname><given-names>K</given-names></name><name><surname>Perret</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Type I IFN signaling constrains IL-17A/F secretion by gammadelta T cells during bacterial infections</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>3755</fpage>&#x02013;<lpage>67</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902065</pub-id><?supplied-pmid 20176744?><pub-id pub-id-type="pmid">20176744</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Barczak</surname><given-names>AK</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Murray</surname><given-names>PJ</given-names></name><etal/></person-group>
<article-title>Hypervirulent <italic>M. tuberculosis</italic> W/Beijing strains upregulate type I IFNs and increase expression of negative regulators of the Jak-Stat pathway</article-title>. <source>J Interf Cytokine Res</source> (<year>2005</year>) <volume>701</volume>:<fpage>694</fpage>&#x02013;<lpage>701</lpage><pub-id pub-id-type="doi">10.1089/jir.2005.25.694</pub-id><?supplied-pmid 16318583?><pub-id pub-id-type="pmid">16318583</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desvignes</surname><given-names>L</given-names></name><name><surname>Wolf</surname><given-names>AJ</given-names></name><name><surname>Ernst</surname><given-names>JD</given-names></name></person-group>
<article-title>Dynamic roles of type I and type II IFNs in early infection with <italic>Mycobacterium tuberculosis</italic></article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<fpage>6205</fpage>&#x02013;<lpage>15</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1200255</pub-id><?supplied-pmid 22566567?><pub-id pub-id-type="pmid">22566567</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Andrade</surname><given-names>BB</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Hieny</surname><given-names>S</given-names></name><name><surname>Feng</surname><given-names>CG</given-names></name><name><surname>Caspar</surname><given-names>P</given-names></name><etal/></person-group>
<article-title>Innate and adaptive interferons suppress IL-1&#x003b1; and IL-1&#x003b2; production by distinct pulmonary myeloid subsets during <italic>Mycobacterium tuberculosis</italic> infection</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>35</volume>:<fpage>1023</fpage>&#x02013;<lpage>34</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.12.002</pub-id><?supplied-pmid 22195750?><pub-id pub-id-type="pmid">22195750</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagarajan</surname><given-names>UM</given-names></name><name><surname>Prantner</surname><given-names>D</given-names></name><name><surname>Sikes</surname><given-names>JD</given-names></name><name><surname>Andrews</surname><given-names>CW</given-names></name><name><surname>Goodwin</surname><given-names>AM</given-names></name><name><surname>Nagarajan</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Type I interferon signaling exacerbates <italic>Chlamydia muridarum</italic> genital infection in a murine model</article-title>. <source>Infect Immun</source> (<year>2008</year>) <volume>76</volume>:<fpage>4642</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1128/IAI.00629-08</pub-id><?supplied-pmid 18663004?><pub-id pub-id-type="pmid">18663004</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>H</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Joyee</surname><given-names>AG</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Han</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>Type I IFNs enhance susceptibility to <italic>Chlamydia muridarum</italic> lung infection by enhancing apoptosis of local macrophages</article-title>. <source>J Immunol</source> (<year>2008</year>) <volume>181</volume>:<fpage>2092</fpage>&#x02013;<lpage>102</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.181.3.2092</pub-id><?supplied-pmid 18641348?><pub-id pub-id-type="pmid">18641348</pub-id></mixed-citation></ref><ref id="B77"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richer</surname><given-names>E</given-names></name><name><surname>Prendergast</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>D-E</given-names></name><name><surname>Qureshi</surname><given-names>ST</given-names></name><name><surname>Vidal</surname><given-names>SM</given-names></name><name><surname>Malo</surname><given-names>D</given-names></name></person-group>
<article-title>N-ethyl-N-nitrosourea-induced mutation in ubiquitin-specific peptidase 18 causes hyperactivation of IFN-&#x003b1;&#x000df; signaling and suppresses STAT4-induced IFN-&#x003b3; production, resulting in increased susceptibility to <italic>Salmonella typhimurium</italic></article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>:<fpage>3593</fpage>&#x02013;<lpage>601</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1000890</pub-id><?supplied-pmid 20693420?><pub-id pub-id-type="pmid">20693420</pub-id></mixed-citation></ref><ref id="B78"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manca</surname><given-names>C</given-names></name><name><surname>Tsenova</surname><given-names>L</given-names></name><name><surname>Bergtold</surname><given-names>A</given-names></name><name><surname>Freeman</surname><given-names>S</given-names></name><name><surname>Tovey</surname><given-names>M</given-names></name><name><surname>Musser</surname><given-names>JM</given-names></name><etal/></person-group>
<article-title>Virulence of a <italic>Mycobacterium tuberculosis</italic> clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2001</year>) <volume>98</volume>:<fpage>5752</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1073/pnas.091096998</pub-id><?supplied-pmid 11320211?><pub-id pub-id-type="pmid">11320211</pub-id></mixed-citation></ref><ref id="B79"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reutterer</surname><given-names>B</given-names></name><name><surname>Stockinger</surname><given-names>S</given-names></name><name><surname>Pilz</surname><given-names>A</given-names></name><name><surname>Soulat</surname><given-names>D</given-names></name><name><surname>Kastner</surname><given-names>R</given-names></name><name><surname>Westermayer</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Type I IFN are host modulators of strain-specific <italic>Listeria monocytogenes</italic> virulence</article-title>. <source>Cell Microbiol</source> (<year>2008</year>) <volume>10</volume>:<fpage>1116</fpage>&#x02013;<lpage>29</lpage><pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.01114.x</pub-id><?supplied-pmid 18182083?><pub-id pub-id-type="pmid">18182083</pub-id></mixed-citation></ref><ref id="B80"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Antonelli</surname><given-names>L</given-names></name><name><surname>Rothfuchs</surname><given-names>A</given-names></name><name><surname>Goncalves</surname><given-names>R</given-names></name><name><surname>Roffe</surname><given-names>E</given-names></name><name><surname>Cheever</surname><given-names>AW</given-names></name><name><surname>Bafica</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Intranasal poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population</article-title>. <source>J Clin Invest</source> (<year>2010</year>) <volume>120</volume>:<fpage>1674</fpage>&#x02013;<lpage>82</lpage><pub-id pub-id-type="doi">10.1172/JCI40817DS1</pub-id><?supplied-pmid 20389020?><pub-id pub-id-type="pmid">20389020</pub-id></mixed-citation></ref><ref id="B81"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarini</surname><given-names>AA</given-names></name><name><surname>Recher</surname><given-names>M</given-names></name><name><surname>Lang</surname><given-names>KS</given-names></name><name><surname>Georgiev</surname><given-names>P</given-names></name><name><surname>Meury</surname><given-names>S</given-names></name><name><surname>Bergthaler</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2006</year>) <volume>103</volume>:<fpage>15535</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.0607325103</pub-id><?supplied-pmid 17030789?><pub-id pub-id-type="pmid">17030789</pub-id></mixed-citation></ref><ref id="B82"><label>82</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhat</surname><given-names>N</given-names></name><name><surname>Wright</surname><given-names>JG</given-names></name><name><surname>Broder</surname><given-names>KR</given-names></name><name><surname>Murray</surname><given-names>EL</given-names></name><name><surname>Greenberg</surname><given-names>ME</given-names></name><name><surname>Glover</surname><given-names>MJ</given-names></name><etal/></person-group>
<article-title>Influenza-associated deaths among children in the United States, 2003-2004</article-title>. <source>N Engl J Med</source> (<year>2005</year>) <volume>353</volume>:<fpage>2559</fpage>&#x02013;<lpage>67</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa051721</pub-id><pub-id pub-id-type="pmid">16354892</pub-id></mixed-citation></ref><ref id="B83"><label>83</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simonsen</surname><given-names>L</given-names></name></person-group>
<article-title>The global impact of influenza on morbidity and mortality</article-title>. <source>Vaccine</source> (<year>1999</year>) <volume>17</volume>(<issue>Suppl 1</issue>):<fpage>S3</fpage>&#x02013;<lpage>10</lpage><pub-id pub-id-type="doi">10.1016/S0264-410X(99)00099-7</pub-id><pub-id pub-id-type="pmid">10471173</pub-id></mixed-citation></ref><ref id="B84"><label>84</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morens</surname><given-names>DM</given-names></name><name><surname>Taubenberger</surname><given-names>JK</given-names></name><name><surname>Fauci</surname><given-names>AS</given-names></name></person-group>
<article-title>Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness</article-title>. <source>J Infect Dis</source> (<year>2008</year>) <volume>198</volume>:<fpage>962</fpage>&#x02013;<lpage>70</lpage><pub-id pub-id-type="doi">10.1086/591708</pub-id><pub-id pub-id-type="pmid">18710327</pub-id></mixed-citation></ref><ref id="B85"><label>85</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shahangian</surname><given-names>A</given-names></name><name><surname>Chow</surname><given-names>EK</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Kang</surname><given-names>JR</given-names></name><name><surname>Ghaffari</surname><given-names>A</given-names></name><name><surname>Liu</surname><given-names>SY</given-names></name><etal/></person-group>
<article-title>Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice</article-title>. <source>J Clin Invest</source> (<year>2009</year>) <volume>119</volume>:<fpage>1910</fpage>&#x02013;<lpage>20</lpage><pub-id pub-id-type="doi">10.1172/JCI35412.1910</pub-id><?supplied-pmid 19487810?><pub-id pub-id-type="pmid">19487810</pub-id></mixed-citation></ref><ref id="B86"><label>86</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>CL</given-names></name><name><surname>Al-Bedwawi</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Garber</surname><given-names>G</given-names></name></person-group>
<article-title>Rate of infectious complications during interferon-based therapy for hepatitis C is not related to neutropenia</article-title>. <source>Clin Infect Dis</source> (<year>2006</year>) <volume>42</volume>:<fpage>1674</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.1086/504386</pub-id><?supplied-pmid 16705570?><pub-id pub-id-type="pmid">16705570</pub-id></mixed-citation></ref><ref id="B87"><label>87</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>J-F</given-names></name><name><surname>Hsieh</surname><given-names>M-Y</given-names></name><name><surname>Hou</surname><given-names>N-J</given-names></name><name><surname>Dai</surname><given-names>C-Y</given-names></name><name><surname>Huang</surname><given-names>J-F</given-names></name><name><surname>Lin</surname><given-names>Z-Y</given-names></name><etal/></person-group>
<article-title>Bacterial infection and neutropenia during peginterferon plus ribavirin combination therapy in patients with chronic hepatitis C with and without baseline neutropenia in clinical practice</article-title>. <source>Aliment Pharmacol Ther</source> (<year>2009</year>) <volume>29</volume>:<fpage>1000</fpage>&#x02013;<lpage>10</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2036.2009.03957.x</pub-id><?supplied-pmid 19210290?><pub-id pub-id-type="pmid">19210290</pub-id></mixed-citation></ref><ref id="B88"><label>88</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roomer</surname><given-names>R</given-names></name><name><surname>Hansen</surname><given-names>BE</given-names></name><name><surname>Janssen</surname><given-names>HLA</given-names></name><name><surname>de Knegt</surname><given-names>RJ</given-names></name></person-group>
<article-title>Risk factors for infection during treatment with peginterferon alfa and ribavirin for chronic hepatitis C</article-title>. <source>Hepatology</source> (<year>2010</year>) <volume>52</volume>:<fpage>1225</fpage>&#x02013;<lpage>31</lpage><pub-id pub-id-type="doi">10.1002/hep.23842</pub-id><?supplied-pmid 20830784?><pub-id pub-id-type="pmid">20830784</pub-id></mixed-citation></ref><ref id="B89"><label>89</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MPR</given-names></name><name><surname>Graham</surname><given-names>CM</given-names></name><name><surname>McNab</surname><given-names>FW</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Bloch</surname><given-names>SAA</given-names></name><name><surname>Oni</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title>. <source>Nature</source> (<year>2010</year>) <volume>466</volume>:<fpage>973</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nature09247</pub-id><pub-id pub-id-type="pmid">20725040</pub-id></mixed-citation></ref><ref id="B90"><label>90</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teles</surname><given-names>RMB</given-names></name><name><surname>Graeber</surname><given-names>TG</given-names></name><name><surname>Krutzik</surname><given-names>SR</given-names></name><name><surname>Montoya</surname><given-names>D</given-names></name><name><surname>Schenk</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>DJ</given-names></name><etal/></person-group>
<article-title>Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses</article-title>. <source>Science</source> (<year>2013</year>) <volume>339</volume>:<fpage>1448</fpage>&#x02013;<lpage>53</lpage><pub-id pub-id-type="doi">10.1126/science.1233665</pub-id><?supplied-pmid 23449998?><pub-id pub-id-type="pmid">23449998</pub-id></mixed-citation></ref><ref id="B91"><label>91</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carrero</surname><given-names>JA</given-names></name><name><surname>Calderon</surname><given-names>B</given-names></name><name><surname>Unanue</surname><given-names>ER</given-names></name></person-group>
<article-title>Lymphocytes are detrimental during the early innate immune response against <italic>Listeria monocytogenes</italic></article-title>. <source>J Exp Med</source> (<year>2006</year>) <volume>203</volume>:<fpage>933</fpage>&#x02013;<lpage>40</lpage><pub-id pub-id-type="doi">10.1084/jem.20060045</pub-id><?supplied-pmid 16549598?><pub-id pub-id-type="pmid">16549598</pub-id></mixed-citation></ref><ref id="B92"><label>92</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emmerling</surname><given-names>P</given-names></name><name><surname>Finger</surname><given-names>H</given-names></name><name><surname>Bockem&#x000fc;hl</surname><given-names>J</given-names></name></person-group>
<article-title><italic>Listeria monocytogenes</italic> infection in nude mice</article-title>. <source>Infect Immun</source> (<year>1975</year>) <volume>12</volume>:<fpage>437</fpage>&#x02013;<lpage>9</lpage><?supplied-pmid 807526?><pub-id pub-id-type="pmid">807526</pub-id></mixed-citation></ref><ref id="B93"><label>93</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname><given-names>T</given-names></name><name><surname>Mieno</surname><given-names>M</given-names></name><name><surname>Udono</surname><given-names>H</given-names></name><name><surname>Yamaguchi</surname><given-names>K</given-names></name><name><surname>Usui</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>K</given-names></name><etal/></person-group>
<article-title>Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine interferon gamma in listerial infection</article-title>. <source>J Exp Med</source> (<year>1990</year>) <volume>171</volume>:<fpage>1141</fpage>&#x02013;<lpage>54</lpage><pub-id pub-id-type="doi">10.1084/jem.171.4.1141</pub-id><?supplied-pmid 2109036?><pub-id pub-id-type="pmid">2109036</pub-id></mixed-citation></ref><ref id="B94"><label>94</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickol</surname><given-names>AD</given-names></name><name><surname>Bonventre</surname><given-names>PF</given-names></name></person-group>
<article-title>Anomalous high native resistance to athymic mice to bacterial pathogens</article-title>. <source>Infect Immun</source> (<year>1977</year>) <volume>18</volume>:<fpage>636</fpage>&#x02013;<lpage>45</lpage><?supplied-pmid 412787?><pub-id pub-id-type="pmid">412787</pub-id></mixed-citation></ref><ref id="B95"><label>95</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>S-J</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name></person-group>
<article-title>Reduced apoptosis and ameliorated listeriosis in TRAIL-null mice</article-title>. <source>J Immunol</source> (<year>2004</year>) <volume>173</volume>:<fpage>5652</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.173.9.5652</pub-id><?supplied-pmid 15494516?><pub-id pub-id-type="pmid">15494516</pub-id></mixed-citation></ref><ref id="B96"><label>96</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cousens</surname><given-names>L</given-names></name><name><surname>Orange</surname><given-names>J</given-names></name><name><surname>Su</surname><given-names>H</given-names></name><name><surname>Biron</surname><given-names>C</given-names></name></person-group>
<article-title>Interferon-a/b inhibition of interleukin 12 and interferon-g production in vitro and endogenously during viral infection</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>1997</year>) <volume>94</volume>:<fpage>634</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1073/pnas.94.2.634</pub-id><?supplied-pmid 9012836?><pub-id pub-id-type="pmid">9012836</pub-id></mixed-citation></ref><ref id="B97"><label>97</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guarda</surname><given-names>G</given-names></name><name><surname>Braun</surname><given-names>M</given-names></name><name><surname>Staehli</surname><given-names>F</given-names></name><name><surname>Tardivel</surname><given-names>A</given-names></name><name><surname>Mattmann</surname><given-names>C</given-names></name><name><surname>F&#x000f6;rster</surname><given-names>I</given-names></name><etal/></person-group>
<article-title>Type I interferon inhibits interleukin-1 production and inflammasome activation</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<fpage>213</fpage>&#x02013;<lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.006</pub-id><?supplied-pmid 21349431?><pub-id pub-id-type="pmid">21349431</pub-id></mixed-citation></ref><ref id="B98"><label>98</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><name><surname>Barber</surname><given-names>DL</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>White</surname><given-names>SD</given-names></name><name><surname>Wilson</surname><given-names>MS</given-names></name><name><surname>Cheever</surname><given-names>A</given-names></name><etal/></person-group>
<article-title>Caspase-1 independent IL-1beta production is critical for host resistance to <italic>Mycobacterium tuberculosis</italic> and does not require TLR signaling in vivo</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>3326</fpage>&#x02013;<lpage>30</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0904189</pub-id><?supplied-pmid 20200276?><pub-id pub-id-type="pmid">20200276</pub-id></mixed-citation></ref><ref id="B99"><label>99</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novikov</surname><given-names>A</given-names></name><name><surname>Cardone</surname><given-names>M</given-names></name><name><surname>Thompson</surname><given-names>R</given-names></name><name><surname>Shenderov</surname><given-names>K</given-names></name><name><surname>Kirschman</surname><given-names>KD</given-names></name><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><etal/></person-group>
<article-title><italic>Mycobacterium tuberculosis</italic> triggers host type I IFN signaling to regulate IL-1&#x003b2; production in human macrophages</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>2540</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1100926</pub-id><?supplied-pmid 21784976?><pub-id pub-id-type="pmid">21784976</pub-id></mixed-citation></ref><ref id="B100"><label>100</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brzoza-Lewis</surname><given-names>KL</given-names></name><name><surname>Hoth</surname><given-names>JJ</given-names></name><name><surname>Hiltbold</surname><given-names>EM</given-names></name></person-group>
<article-title>Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with <italic>Listeria monocytogenes</italic></article-title>. <source>Cell Immunol</source> (<year>2012</year>) <volume>273</volume>:<fpage>41</fpage>&#x02013;<lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.cellimm.2011.11.008</pub-id><?supplied-pmid 22212606?><pub-id pub-id-type="pmid">22212606</pub-id></mixed-citation></ref><ref id="B101"><label>101</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Davis</surname><given-names>KM</given-names></name><name><surname>Weiser</surname><given-names>JN</given-names></name></person-group>
<article-title>Synergistic stimulation of type I interferons during influenza virus coinfection promotes <italic>Streptococcus pneumoniae</italic> colonization in mice</article-title>. <source>J Clin Invest</source> (<year>2011</year>) <volume>121</volume>:<fpage>3657</fpage>&#x02013;<lpage>65</lpage><pub-id pub-id-type="doi">10.1172/JCI57762.of</pub-id><?supplied-pmid 21841308?><pub-id pub-id-type="pmid">21841308</pub-id></mixed-citation></ref><ref id="B102"><label>102</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serbina</surname><given-names>NV</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group>
<article-title>Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2</article-title>. <source>Nat Immunol</source> (<year>2006</year>) <volume>7</volume>:<fpage>311</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1038/ni1309</pub-id><pub-id pub-id-type="pmid">16462739</pub-id></mixed-citation></ref><ref id="B103"><label>103</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kurihara</surname><given-names>T</given-names></name><name><surname>Warr</surname><given-names>G</given-names></name><name><surname>Loy</surname><given-names>J</given-names></name><name><surname>Bravo</surname><given-names>R</given-names></name></person-group>
<article-title>Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor</article-title>. <source>J Exp Med</source> (<year>1997</year>) <volume>186</volume>:<fpage>1757</fpage>&#x02013;<lpage>62</lpage><pub-id pub-id-type="doi">10.1084/jem.186.10.1757</pub-id><?supplied-pmid 9362535?><pub-id pub-id-type="pmid">9362535</pub-id></mixed-citation></ref><ref id="B104"><label>104</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serbina</surname><given-names>NV</given-names></name><name><surname>Jia</surname><given-names>T</given-names></name><name><surname>Hohl</surname><given-names>TM</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group>
<article-title>Monocyte-mediated defense against microbial pathogens</article-title>. <source>Annu Rev Immunol</source> (<year>2008</year>) <volume>26</volume>:<fpage>421</fpage>&#x02013;<lpage>52</lpage><pub-id pub-id-type="doi">10.1146/annurev.immunol.26.021607.090326</pub-id><?supplied-pmid 18303997?><pub-id pub-id-type="pmid">18303997</pub-id></mixed-citation></ref><ref id="B105"><label>105</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>KD</given-names></name><name><surname>Sieve</surname><given-names>AN</given-names></name><name><surname>Indramohan</surname><given-names>M</given-names></name><name><surname>Break</surname><given-names>TJ</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Berg</surname><given-names>RE</given-names></name></person-group>
<article-title>Specific depletion reveals a novel role for neutrophil-mediated protection in the liver during <italic>Listeria monocytogenes</italic> infection</article-title>. <source>Eur J Immunol</source> (<year>2011</year>) <volume>41</volume>:<fpage>2666</fpage>&#x02013;<lpage>76</lpage><pub-id pub-id-type="doi">10.1002/eji.201041363</pub-id><?supplied-pmid 21660934?><pub-id pub-id-type="pmid">21660934</pub-id></mixed-citation></ref><ref id="B106"><label>106</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>C</given-names></name><name><surname>Hohl</surname><given-names>TM</given-names></name><name><surname>Leiner</surname><given-names>I</given-names></name><name><surname>Equinda</surname><given-names>MJ</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Pamer</surname><given-names>EG</given-names></name></person-group>
<article-title>Ly6G+ neutrophils are dispensable for defense against systemic <italic>Listeria monocytogenes</italic> infection</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>5293</fpage>&#x02013;<lpage>8</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1101721</pub-id><?supplied-pmid 21976773?><pub-id pub-id-type="pmid">21976773</pub-id></mixed-citation></ref><ref id="B107"><label>107</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lykens</surname><given-names>JE</given-names></name><name><surname>Terrell</surname><given-names>CE</given-names></name><name><surname>Zoller</surname><given-names>EE</given-names></name><name><surname>Divanovic</surname><given-names>S</given-names></name><name><surname>Trompette</surname><given-names>A</given-names></name><name><surname>Karp</surname><given-names>CL</given-names></name><etal/></person-group>
<article-title>Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivo</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>184</volume>:<fpage>877</fpage>&#x02013;<lpage>85</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0902346</pub-id><?supplied-pmid 20018611?><pub-id pub-id-type="pmid">20018611</pub-id></mixed-citation></ref><ref id="B108"><label>108</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reith</surname><given-names>W</given-names></name><name><surname>LeibundGut-Landmann</surname><given-names>S</given-names></name><name><surname>Waldburger</surname><given-names>J-M</given-names></name></person-group>
<article-title>Regulation of MHC class II gene expression by the class II transactivator</article-title>. <source>Nat Rev Immunol</source> (<year>2005</year>) <volume>5</volume>:<fpage>793</fpage>&#x02013;<lpage>806</lpage><pub-id pub-id-type="doi">10.1038/nri1708</pub-id><?supplied-pmid 16200082?><pub-id pub-id-type="pmid">16200082</pub-id></mixed-citation></ref><ref id="B109"><label>109</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>EB</given-names></name><name><surname>Yamada</surname><given-names>DH</given-names></name><name><surname>Elsaesser</surname><given-names>H</given-names></name><name><surname>Herskovitz</surname><given-names>J</given-names></name><name><surname>Deng</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>G</given-names></name><etal/></person-group>
<article-title>Blockade of chronic type I interferon signaling to control persistent LCMV infection</article-title>. <source>Science</source> (<year>2013</year>) <volume>340</volume>:<fpage>202</fpage>&#x02013;<lpage>7</lpage><pub-id pub-id-type="doi">10.1126/science.1235208</pub-id><?supplied-pmid 23580528?><pub-id pub-id-type="pmid">23580528</pub-id></mixed-citation></ref><ref id="B110"><label>110</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teijaro</surname><given-names>JR</given-names></name><name><surname>Ng</surname><given-names>C</given-names></name><name><surname>Lee</surname><given-names>AM</given-names></name><name><surname>Sullivan</surname><given-names>BM</given-names></name><name><surname>Sheehan</surname><given-names>KCF</given-names></name><name><surname>Welch</surname><given-names>M</given-names></name><etal/></person-group>
<article-title>Persistent LCMV infection is controlled by blockade of type I interferon signaling</article-title>. <source>Science</source> (<year>2013</year>) <volume>340</volume>:<fpage>207</fpage>&#x02013;<lpage>11</lpage><pub-id pub-id-type="doi">10.1126/science.1235214</pub-id><?supplied-pmid 23580529?><pub-id pub-id-type="pmid">23580529</pub-id></mixed-citation></ref><ref id="B111"><label>111</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singhal</surname><given-names>A</given-names></name><name><surname>Jaiswal</surname><given-names>A</given-names></name><name><surname>Arora</surname><given-names>VK</given-names></name><name><surname>Prasad</surname><given-names>HK</given-names></name></person-group>
<article-title>Modulation of gamma interferon receptor 1 by <italic>Mycobacterium tuberculosis</italic>: a potential immune response evasive mechanism</article-title>. <source>Infect Immun</source> (<year>2007</year>) <volume>75</volume>:<fpage>2500</fpage>&#x02013;<lpage>10</lpage><pub-id pub-id-type="doi">10.1128/IAI.01743-06</pub-id><?supplied-pmid 17339358?><pub-id pub-id-type="pmid">17339358</pub-id></mixed-citation></ref><ref id="B112"><label>112</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kearney</surname><given-names>SJ</given-names></name><name><surname>Delgado</surname><given-names>C</given-names></name><name><surname>Eshleman</surname><given-names>EM</given-names></name><name><surname>Hill</surname><given-names>KK</given-names></name><name><surname>O&#x02019;Connor</surname><given-names>BP</given-names></name><name><surname>Lenz</surname><given-names>LL</given-names></name></person-group>
<article-title>Type I IFNs downregulate myeloid cell IFN-&#x003b3; receptor by inducing recruitment of an early growth response 3/NGFI-A binding protein 1 complex that silences ifngr1 transcription</article-title>. <source>J Immunol</source> (<year>2013</year>) <volume>191</volume>:<fpage>3384</fpage>&#x02013;<lpage>92</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1203510</pub-id><?supplied-pmid 23935197?><pub-id pub-id-type="pmid">23935197</pub-id></mixed-citation></ref><ref id="B113"><label>113</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>KM</given-names></name><name><surname>Gunn</surname><given-names>JS</given-names></name><name><surname>Lafuse</surname><given-names>W</given-names></name><name><surname>Satoskar</surname><given-names>AR</given-names></name></person-group>
<article-title><italic>Francisella</italic> inhibits STAT1-mediated signaling in macrophages and prevents activation of antigen-specific T cells</article-title>. <source>Int Immunol</source> (<year>2009</year>) <volume>21</volume>:<fpage>19</fpage>&#x02013;<lpage>28</lpage><pub-id pub-id-type="doi">10.1093/intimm/dxn119</pub-id><?supplied-pmid 19001470?><pub-id pub-id-type="pmid">19001470</pub-id></mixed-citation></ref><ref id="B114"><label>114</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O&#x02019;Donovan</surname><given-names>KJ</given-names></name><name><surname>Tourtellotte</surname><given-names>WG</given-names></name><name><surname>Millbrandt</surname><given-names>J</given-names></name><name><surname>Baraban</surname><given-names>JM</given-names></name></person-group>
<article-title>The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience</article-title>. <source>Trends Neurosci</source> (<year>1999</year>) <volume>22</volume>:<fpage>167</fpage>&#x02013;<lpage>73</lpage><pub-id pub-id-type="doi">10.1016/S0166-2236(98)01343-5</pub-id><?supplied-pmid 10203854?><pub-id pub-id-type="pmid">10203854</pub-id></mixed-citation></ref><ref id="B115"><label>115</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Swirnoff</surname><given-names>A</given-names></name><name><surname>Milbrandt</surname><given-names>J</given-names></name></person-group>
<article-title>DNA-binding specificity of NGFI-A and related zinc finger transcription factors</article-title>. <source>Mol Cell Biol</source> (<year>1995</year>) <volume>15</volume>:<fpage>2275</fpage>&#x02013;<lpage>87</lpage><?supplied-pmid 7891721?><pub-id pub-id-type="pmid">7891721</pub-id></mixed-citation></ref><ref id="B116"><label>116</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>J</given-names></name><name><surname>de Belle</surname><given-names>I</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Adamson</surname><given-names>ED</given-names></name></person-group>
<article-title>Coactivating factors p300 and CBP are transcriptionally crossregulated by Egr1 in prostate cells, leading to divergent responses</article-title>. <source>Mol Cell</source> (<year>2004</year>) <volume>15</volume>:<fpage>83</fpage>&#x02013;<lpage>94</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2004.06.030</pub-id><?supplied-pmid 15225550?><pub-id pub-id-type="pmid">15225550</pub-id></mixed-citation></ref><ref id="B117"><label>117</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>RP</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>deBelle</surname><given-names>I</given-names></name><name><surname>Ni</surname><given-names>Z</given-names></name><name><surname>Matheny</surname><given-names>W</given-names></name><name><surname>Adamson</surname><given-names>ED</given-names></name></person-group>
<article-title>Egr-1 inhibits apoptosis during the UV response: correlation of cell survival with Egr-1 phosphorylation</article-title>. <source>Cell Death Differ</source> (<year>1998</year>) <volume>5</volume>:<fpage>96</fpage>&#x02013;<lpage>106</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4400322</pub-id><?supplied-pmid 10200450?><pub-id pub-id-type="pmid">10200450</pub-id></mixed-citation></ref><ref id="B118"><label>118</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>KM</given-names></name><name><surname>Stewart</surname><given-names>SE</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Woodman</surname><given-names>CBJ</given-names></name><name><surname>O&#x02019;Neil</surname><given-names>JD</given-names></name><name><surname>Dawson</surname><given-names>CW</given-names></name><etal/></person-group>
<article-title>The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation</article-title>. <source>Oncogene</source> (<year>2009</year>) <volume>28</volume>:<fpage>3903</fpage>&#x02013;<lpage>14</lpage><pub-id pub-id-type="doi">10.1038/onc.2009.249</pub-id><?supplied-pmid 19718044?><pub-id pub-id-type="pmid">19718044</pub-id></mixed-citation></ref><ref id="B119"><label>119</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Thai</surname><given-names>V</given-names></name><name><surname>McCabe</surname><given-names>A</given-names></name><name><surname>Jones</surname><given-names>M</given-names></name><name><surname>Macnamara</surname><given-names>KC</given-names></name></person-group>
<article-title>Type I interferons promote severe disease in a mouse model of lethal ehrlichiosis</article-title>. <source>Infect Immun</source> (<year>2014</year>) <volume>82</volume>:<fpage>1698</fpage>&#x02013;<lpage>709</lpage><pub-id pub-id-type="doi">10.1128/IAI.01564-13</pub-id><?supplied-pmid 24491580?><pub-id pub-id-type="pmid">24491580</pub-id></mixed-citation></ref><ref id="B120"><label>120</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kernbauer</surname><given-names>E</given-names></name><name><surname>Maier</surname><given-names>V</given-names></name><name><surname>Rauch</surname><given-names>I</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>M</given-names></name><name><surname>Decker</surname><given-names>T</given-names></name></person-group>
<article-title>Route of infection determines the impact of type I interferons on innate immunity to <italic>Listeria monocytogenes</italic></article-title>. <source>PLoS One</source> (<year>2013</year>) <volume>8</volume>:<fpage>e65007</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0065007</pub-id><?supplied-pmid 23840314?><pub-id pub-id-type="pmid">23840314</pub-id></mixed-citation></ref><ref id="B121"><label>121</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baechler</surname><given-names>EC</given-names></name><name><surname>Batliwalla</surname><given-names>FM</given-names></name><name><surname>Karypis</surname><given-names>G</given-names></name><name><surname>Gaffney</surname><given-names>PM</given-names></name><name><surname>Ortmann</surname><given-names>WA</given-names></name><name><surname>Espe</surname><given-names>KJ</given-names></name><etal/></person-group>
<article-title>Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2003</year>) <volume>100</volume>:<fpage>2610</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="doi">10.1073/pnas.0337679100</pub-id><?supplied-pmid 12604793?><pub-id pub-id-type="pmid">12604793</pub-id></mixed-citation></ref><ref id="B122"><label>122</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirou</surname><given-names>KA</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>George</surname><given-names>S</given-names></name><name><surname>Louca</surname><given-names>K</given-names></name><name><surname>Peterson</surname><given-names>MGE</given-names></name><name><surname>Crow</surname><given-names>MK</given-names></name></person-group>
<article-title>Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease</article-title>. <source>Arthritis Rheum</source> (<year>2005</year>) <volume>52</volume>:<fpage>1491</fpage>&#x02013;<lpage>503</lpage><pub-id pub-id-type="doi">10.1002/art.21031</pub-id><pub-id pub-id-type="pmid">15880830</pub-id></mixed-citation></ref><ref id="B123"><label>123</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>L</given-names></name><name><surname>Palucka</surname><given-names>AK</given-names></name><name><surname>Arce</surname><given-names>E</given-names></name><name><surname>Cantrell</surname><given-names>V</given-names></name><name><surname>Borvak</surname><given-names>J</given-names></name><name><surname>Banchereau</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Interferon and granulopoiesis signatures in systemic lupus erythematosus blood</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>197</volume>:<fpage>711</fpage>&#x02013;<lpage>23</lpage><pub-id pub-id-type="doi">10.1084/jem.20021553</pub-id><?supplied-pmid 12642603?><pub-id pub-id-type="pmid">12642603</pub-id></mixed-citation></ref><ref id="B124"><label>124</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hall</surname><given-names>JC</given-names></name><name><surname>Rosen</surname><given-names>A</given-names></name></person-group>
<article-title>Type I interferons: crucial participants in disease amplification in autoimmunity</article-title>. <source>Nat Rev Rheumatol</source> (<year>2010</year>) <volume>6</volume>:<fpage>40</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1038/nrrheum.2009.237</pub-id><?supplied-pmid 20046205?><pub-id pub-id-type="pmid">20046205</pub-id></mixed-citation></ref><ref id="B125"><label>125</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waubant</surname><given-names>E</given-names></name><name><surname>Vukusic</surname><given-names>S</given-names></name><name><surname>Gignoux</surname><given-names>L</given-names></name><name><surname>Dubief</surname><given-names>FD</given-names></name><name><surname>Achiti</surname><given-names>I</given-names></name><name><surname>Blanc</surname><given-names>S</given-names></name><etal/></person-group>
<article-title>Clinical characteristics of responders to interferon therapy for relapsing MS</article-title>. <source>Neurology</source> (<year>2003</year>) <volume>61</volume>:<fpage>184</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1212/01.WNL.0000078888.07196.0B</pub-id><?supplied-pmid 12874396?><pub-id pub-id-type="pmid">12874396</pub-id></mixed-citation></ref><ref id="B126"><label>126</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teige</surname><given-names>I</given-names></name><name><surname>Treschow</surname><given-names>A</given-names></name><name><surname>Teige</surname><given-names>A</given-names></name><name><surname>Mattsson</surname><given-names>R</given-names></name><name><surname>Navikas</surname><given-names>V</given-names></name><name><surname>Leanderson</surname><given-names>T</given-names></name><etal/></person-group>
<article-title>IFN-B gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis</article-title>. <source>J Immunol</source> (<year>2003</year>) <volume>170</volume>:<fpage>4776</fpage>&#x02013;<lpage>84</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.170.9.4776</pub-id><?supplied-pmid 12707359?><pub-id pub-id-type="pmid">12707359</pub-id></mixed-citation></ref><ref id="B127"><label>127</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prinz</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>H</given-names></name><name><surname>Mildner</surname><given-names>A</given-names></name><name><surname>Knobeloch</surname><given-names>K-P</given-names></name><name><surname>Hanisch</surname><given-names>U-K</given-names></name><name><surname>Raasch</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>28</volume>:<fpage>675</fpage>&#x02013;<lpage>86</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2008.03.011</pub-id><?supplied-pmid 18424188?><pub-id pub-id-type="pmid">18424188</pub-id></mixed-citation></ref><ref id="B128"><label>128</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tak</surname><given-names>P</given-names></name><name><surname>Hart</surname><given-names>B</given-names></name><name><surname>Kraan</surname><given-names>M</given-names></name></person-group>
<article-title>The effects of interferon beta treatment on arthritis</article-title>. <source>Rheumatology</source> (<year>1999</year>) <volume>38</volume>:<fpage>362</fpage>&#x02013;<lpage>9</lpage><pub-id pub-id-type="doi">10.1093/rheumatology/38.4.362</pub-id><pub-id pub-id-type="pmid">10378715</pub-id></mixed-citation></ref><ref id="B129"><label>129</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ying</surname><given-names>F</given-names></name><name><surname>Chalise</surname><given-names>JP</given-names></name><name><surname>Narendra</surname><given-names>SC</given-names></name><name><surname>Magnusson</surname><given-names>M</given-names></name></person-group>
<article-title>Type I IFN protects against antigen-induced arthritis</article-title>. <source>Eur J Immunol</source> (<year>2011</year>) <volume>41</volume>:<fpage>1687</fpage>&#x02013;<lpage>95</lpage><pub-id pub-id-type="doi">10.1002/eji.201040956</pub-id><?supplied-pmid 21469099?><pub-id pub-id-type="pmid">21469099</pub-id></mixed-citation></ref><ref id="B130"><label>130</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mullen</surname><given-names>L</given-names></name><name><surname>Adams</surname><given-names>G</given-names></name><name><surname>Foster</surname><given-names>J</given-names></name><name><surname>Vessillier</surname><given-names>S</given-names></name><name><surname>K&#x000f6;ster</surname><given-names>M</given-names></name><name><surname>Hauser</surname><given-names>H</given-names></name><etal/></person-group>
<article-title>A comparative study of matrix metalloproteinase and aggrecanase mediated release of latent cytokines at arthritic joints</article-title>. <source>Ann Rheum Dis</source> (<year>2013</year>) <volume>73</volume>(<issue>9</issue>):<fpage>1728</fpage>&#x02013;<lpage>36</lpage><pub-id pub-id-type="doi">10.1136/annrheumdis-2013-203513</pub-id><?supplied-pmid 23813971?><pub-id pub-id-type="pmid">23813971</pub-id></mixed-citation></ref><ref id="B131"><label>131</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rhee</surname><given-names>I</given-names></name><name><surname>Veillette</surname><given-names>A</given-names></name></person-group>
<article-title>Protein tyrosine phosphatases in lymphocyte activation and autoimmunity</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>:<fpage>439</fpage>&#x02013;<lpage>47</lpage><pub-id pub-id-type="doi">10.1038/ni.2246</pub-id><?supplied-pmid 22513334?><pub-id pub-id-type="pmid">22513334</pub-id></mixed-citation></ref><ref id="B132"><label>132</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shaked</surname><given-names>I</given-names></name><name><surname>Stanford</surname><given-names>SM</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Curtsinger</surname><given-names>JM</given-names></name><name><surname>Mikulski</surname><given-names>Z</given-names></name><etal/></person-group>
<article-title>The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>39</volume>:<fpage>111</fpage>&#x02013;<lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.immuni.2013.06.013</pub-id><?supplied-pmid 23871208?><pub-id pub-id-type="pmid">23871208</pub-id></mixed-citation></ref><ref id="B133"><label>133</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Rachmilewitz</surname><given-names>D</given-names></name><name><surname>Raz</surname><given-names>E</given-names></name></person-group>
<article-title>Homeostatic effects of TLR9 signaling in experimental colitis</article-title>. <source>Ann N Y Acad Sci</source> (<year>2006</year>) <volume>1072</volume>:<fpage>351</fpage>&#x02013;<lpage>5</lpage><pub-id pub-id-type="doi">10.1196/annals.1326.022</pub-id><?supplied-pmid 17057215?><pub-id pub-id-type="pmid">17057215</pub-id></mixed-citation></ref><ref id="B134"><label>134</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mannon</surname><given-names>PJ</given-names></name><name><surname>Hornung</surname><given-names>RL</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Yi</surname><given-names>C</given-names></name><name><surname>Groden</surname><given-names>C</given-names></name><name><surname>Friend</surname><given-names>J</given-names></name><etal/></person-group>
<article-title>Suppression of inflammation in ulcerative colitis by interferon-&#x003b2;-1a is accompanied by inhibition of IL-13 production</article-title>. <source>Gut</source> (<year>2011</year>) <volume>60</volume>:<fpage>449</fpage>&#x02013;<lpage>55</lpage><pub-id pub-id-type="doi">10.1136/gut.2010.226860</pub-id><?supplied-pmid 20971977?><pub-id pub-id-type="pmid">20971977</pub-id></mixed-citation></ref><ref id="B135"><label>135</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nikolaus</surname><given-names>S</given-names></name><name><surname>Rutgeerts</surname><given-names>P</given-names></name><name><surname>Fedorak</surname><given-names>R</given-names></name><name><surname>Steinhart</surname><given-names>AH</given-names></name><name><surname>Wild</surname><given-names>GE</given-names></name><name><surname>Theuer</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Interferon beta-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study</article-title>. <source>Gut</source> (<year>2003</year>) <volume>52</volume>:<fpage>1286</fpage>&#x02013;<lpage>90</lpage><pub-id pub-id-type="doi">10.1136/gut.52.9.1286</pub-id><?supplied-pmid 12912859?><pub-id pub-id-type="pmid">12912859</pub-id></mixed-citation></ref><ref id="B136"><label>136</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauch</surname><given-names>I</given-names></name><name><surname>Hainzl</surname><given-names>E</given-names></name><name><surname>Rosebrock</surname><given-names>F</given-names></name><name><surname>Heider</surname><given-names>S</given-names></name><name><surname>Schwab</surname><given-names>C</given-names></name><name><surname>Stoiber</surname><given-names>D</given-names></name><etal/></person-group>
<article-title>Type I interferons have opposing effects during the emergence and recovery phases of colitis</article-title>. <source>Eur J Cancer</source> (<year>2014</year>).<pub-id pub-id-type="doi">10.1002/eji.201344401</pub-id><?supplied-pmid 24975266?><pub-id pub-id-type="pmid">24975266</pub-id></mixed-citation></ref><ref id="B137"><label>137</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katakura</surname><given-names>K</given-names></name><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Rachmilewitz</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Eckmann</surname><given-names>L</given-names></name><name><surname>Raz</surname><given-names>E</given-names></name></person-group>
<article-title>Toll-like receptor 9 &#x02013; induced type I IFN protects mice from experimental colitis</article-title>. <source>J Clin Invest</source> (<year>2005</year>) <volume>115</volume>:<fpage>695</fpage>&#x02013;<lpage>702</lpage><pub-id pub-id-type="doi">10.1172/JCI200522996DS1</pub-id><?supplied-pmid 15765149?><pub-id pub-id-type="pmid">15765149</pub-id></mixed-citation></ref></